Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: NORTHWESTERN UNIVERSITY
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-27 to 2024-03-29
Current total value of award: $350353
Description: THERE IS INCREASING RECOGNITION OF THE IMPORTANT ROLE OF PATIENT-FOCUSED DRUG DEVELOPMENT (PFDD) IN ONCOLOGY. REFLECTING THIS, THE FDA?S ONCOLOGY CENTER OF EXCELLENCE'S (OCE) PFDD PROGRAM IDENTIFIES RESEARCH INTO MEASUREMENT OF PATIENT EXPERI